Languages
HGF Partners Craig Thomson and Dr Andrew Wells will be presenting a webinar on 'Attracting Big Pharma to the Microbiome Field' on 8th July.
This page provides information on any HGF office closures that may happen as a result of Corona virus safety measures in Europe and the UK.
HGF Partner Leythem Wall will be presenting a webinar on “Priority” on 1st July and on “Clarity” on 8th July.
In its long-awaited judgment on the dispute over patents for transgenic mice, the UK Supreme Court has held by a majority (Lady Black dissenting) that Regeneron’s patents are invalid for a lack of sufficiency (Regeneron Pharmaceuticals Inc (Respondent) v Kymab Ltd (Appellant) [2020] UKSC 27).
The taking of new therapies and technologies forward to meet the challenges of COVID-19 is happening at previously unprecedented rates. MHRA is taking flexible approaches to regulation during the COVID-19 outbreak. This includes providing expedited scientific advice, and rapid reviews of clinical trials applications.